Literature DB >> 30231858

Activation of RAAS in a rat model of liver cirrhosis: no effect of losartan on renal sodium excretion.

A D Fialla1, O B Schaffalitzky de Muckadell2, P Bie3, H C Thiesson4.   

Abstract

BACKGROUND: Liver cirrhosis is characterized by avid sodium retention where the activation of the renin angiotensin aldosterone system (RAAS) is considered to be the hallmark of the sodium retaining mechanisms. The direct effect of angiotensin II (ANGII) on the AT-1 receptor in the proximal tubules is partly responsible for the sodium retention. The aim was to estimate the natriuretic and neurohumoral effects of an ANGII receptor antagonist (losartan) in the late phase of the disease in a rat model of liver cirrhosis.
METHODS: Bile duct ligated (BDL) and sham operated rats received 2 weeks of treatment with losartan 4 mg/kg/day or placebo, given by gastric gavage 5 weeks after surgery. Daily sodium and potassium intakes and renal excretions were measured.
RESULTS: The renal sodium excretion decreased in the BDL animals and this was not affected by losartan treatment. At baseline the plasma renin concentration (PRC) was similar in sham and BDL animals, but increased urinary excretion of ANGII and an increase P-Aldosterone was observed in the placebo treated BDL animals. The PRC was more than 150 times higher in the losartan treated BDL animals (p < 0.001) which indicated hemodynamic impairment.
CONCLUSIONS: Losartan 4 mg/kg/day did not increase renal sodium excretion in this model of liver cirrhosis, although the urinary ANGII excretion was increased. The BDL animals tolerated Losartan poorly, and the treatment induced a 150 times higher PRC.

Entities:  

Keywords:  ANGII antagonists; Aldosterone; Bile duct ligation; Liver cirrhosis; Sodium retention

Mesh:

Substances:

Year:  2018        PMID: 30231858      PMCID: PMC6146747          DOI: 10.1186/s12882-018-1039-6

Source DB:  PubMed          Journal:  BMC Nephrol        ISSN: 1471-2369            Impact factor:   2.388


  25 in total

1.  The effect of single oral low-dose losartan on posture-related sodium handling in post-TIPS ascites-free cirrhosis.

Authors:  George Therapondos; Lieke Hol; Fabiana Benjaminov; Florence Wong
Journal:  Hepatology       Date:  2006-09       Impact factor: 17.425

2.  Renal sodium retention in cirrhotic rats depends on glucocorticoid-mediated activation of mineralocorticoid receptor due to decreased renal 11beta-HSD-2 activity.

Authors:  Helle C Thiesson; Boye L Jensen; Claus Bistrup; Peter D Ottosen; Alison D McNeilly; Ruth Andrew; Jonathan Seckl; Ole Skøtt
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-08-17       Impact factor: 3.619

3.  Systemic hypotension and decreased pressor response in dogs with chronic bile duct ligation.

Authors:  A Bomzon; M Rosenberg; D Gali; O Binah; D Mordechovitz; O S Better; P D Greig; L M Blendis
Journal:  Hepatology       Date:  1986 Jul-Aug       Impact factor: 17.425

Review 4.  Renin-angiotensin-aldosterone inhibitors in the reduction of portal pressure: a systematic review and meta-analysis.

Authors:  Puneeta Tandon; Juan G Abraldes; Annalisa Berzigotti; Juan Carlos Garcia-Pagan; Jaime Bosch
Journal:  J Hepatol       Date:  2010-05-21       Impact factor: 25.083

5.  Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.

Authors:  W Wong; P Liu; L Blendis; F Wong
Journal:  Am J Med       Date:  1999-03       Impact factor: 4.965

6.  Haemodynamic and renal evolution of the bile duct-ligated rat.

Authors:  C Martínez-Prieto; M C Ortíz; L A Fortepiani; J Ruiz-Maciá; N M Atucha; J García-Estañ
Journal:  Clin Sci (Lond)       Date:  2000-05       Impact factor: 6.124

7.  One-week losartan administration increases sodium excretion in cirrhotic patients with and without ascites.

Authors:  Ying-Ying Yang; Han-Chieh Lin; Wui-Chiang Lee; Ming-Chih Hou; Fa-Yauh Lee; Full-Young Chang; Shou-Dong Lee
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

8.  Renin and angiotensinogen mRNA expression in the kidneys of rats subjected to long-term bile duct ligation.

Authors:  M Ubeda; M M Matzilevich; N M Atucha; J García-Estañ; T Quesada; S S Tang; J R Ingelfinger
Journal:  Hepatology       Date:  1994-06       Impact factor: 17.425

9.  The effect of complete biliary obstruction on bile secretion. Studies on the mechanisms of postcholestatic choleresis in the rat.

Authors:  L Accatino; A Contreras; E Berdichevsky; C Quintana
Journal:  J Lab Clin Med       Date:  1981-04

10.  Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension.

Authors:  Vincent Croquet; Frédéric Moal; Nary Veal; Jianhua Wang; Frédéric Oberti; Jérôme Roux; Eric Vuillemin; Yves Gallois; Olivier Douay; Daniel Chappard; Paul Calès
Journal:  J Hepatol       Date:  2002-12       Impact factor: 25.083

View more
  1 in total

1.  Targeting the renin-angiotensin-aldosterone system in fibrosis.

Authors:  Mohammad AlQudah; Taben M Hale; Michael P Czubryt
Journal:  Matrix Biol       Date:  2020-05-16       Impact factor: 11.583

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.